Stay updated on Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added new navigation/help sections—How to Read a Study Record, Common Questions, and How to Join a Study—and a recruitment note stating No longer looking for participants. The Intervention / Treatment heading was normalized to Intervention/Treatment and the page revision stamp updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T13:34:21.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.5.5 indicates a minor page update. It does not change the clinical trial data, eligibility criteria, or how the page is used.
    Difference
    0.1%
    Check dated 2026-06-05T09:58:32.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    - Revision indicator updated from v3.5.3 to v3.5.4, reflecting a new build of the page.
    Difference
    0.1%
    Check dated 2026-05-15T05:44:38.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The site’s release/version indicator for the ClinicalTrials.gov study page has been updated from v3.5.2 to v3.5.3, reflecting a platform or content release change rather than any modification to the study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:45:31.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:51.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The study status changed from Recruiting to Active, not recruiting. Several study contact details and names were removed from the page.
    Difference
    3%
    Check dated 2026-03-26T11:23:19.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.